The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global Valvular Disease Device Market Research Report 2024
Synopsis
It is a market trend for patients to choose valvular disease interventional devices, such as TAVR and TMVr systems, which provide alternative options with lower risk and more rapid recovery.
Global Valvular Disease Device market is projected to reach US$ 17640 million in 2029, increasing from US$ 7851 million in 2022, with the CAGR of 12.3% during the period of 2023 to 2029. Influencing issues, such as economy environments, COVID-19 and Russia-Ukraine War, have led to great market fluctuations in the past few years and are considered comprehensively in the whole Valvular Disease Device market research.
The valvular disease interventional device market is driven by the increasing prevalence of valvular heart diseases and the growing demand for less invasive and effective treatment options. Valvular disease interventional devices are medical devices used to repair or replace damaged heart valves through minimally invasive procedures, such as transcatheter aortic valve replacement (TAVR) or mitral valve repair. The rise in the aging population and the incidence of valvular diseases contribute to market growth as these conditions require specialized interventions. Moreover, advancements in medical technology and the development of innovative devices have improved the outcomes and safety of valvular disease treatments. However, the market also faces challenges, including the high cost of some interventional devices and the need for skilled healthcare professionals trained in interventional cardiology. Additionally, addressing reimbursement issues and ensuring the long-term durability of interventional devices can pose obstacles for manufacturers. To succeed, companies must focus on research and development to offer advanced valvular disease interventional devices, collaborate with healthcare providers to expand awareness and access to treatments, and address the challenges to meet the increasing demand for less invasive and effective solutions for valvular heart diseases.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2023-2029), aims to help readers to get a comprehensive understanding of global Valvular Disease Device market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
By Company
Edwards Lifesciences
Medtronic
Abbott
Boston Scientific
Venus Medtech
Meril Life Sciences
Braile Biomedica
Segment by Type
TAVR
TPVR
TMVR
Segment by Application
Hospitals
Ambulatory Surgical Centers
Cardiac Catheterization Laboratory
Consumption by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
The Valvular Disease Device report covers below items:
Chapter 1: Product Basic Information (Definition, Type and Application)
Chapter 2: Manufacturers’ Competition Patterns
Chapter 3: Country Level Sales Analysis
Chapter 4: Product Type Analysis
Chapter 5: Product Application Analysis
Chapter 6: Manufacturers’ Outline
Chapter 7: Industry Chain, Market Channel and Customer Analysis
Chapter 8: Market Opportunities and Challenges
Chapter 9: Market Conclusions
Chapter 10: Research Methodology and Data Source
It is a market trend for patients to choose valvular disease interventional devices, such as TAVR and TMVr systems, which provide alternative options with lower risk and more rapid recovery.
Global Valvular Disease Device market is projected to reach US$ 17640 million in 2029, increasing from US$ 7851 million in 2022, with the CAGR of 12.3% during the period of 2023 to 2029. Influencing issues, such as economy environments, COVID-19 and Russia-Ukraine War, have led to great market fluctuations in the past few years and are considered comprehensively in the whole Valvular Disease Device market research.
The valvular disease interventional device market is driven by the increasing prevalence of valvular heart diseases and the growing demand for less invasive and effective treatment options. Valvular disease interventional devices are medical devices used to repair or replace damaged heart valves through minimally invasive procedures, such as transcatheter aortic valve replacement (TAVR) or mitral valve repair. The rise in the aging population and the incidence of valvular diseases contribute to market growth as these conditions require specialized interventions. Moreover, advancements in medical technology and the development of innovative devices have improved the outcomes and safety of valvular disease treatments. However, the market also faces challenges, including the high cost of some interventional devices and the need for skilled healthcare professionals trained in interventional cardiology. Additionally, addressing reimbursement issues and ensuring the long-term durability of interventional devices can pose obstacles for manufacturers. To succeed, companies must focus on research and development to offer advanced valvular disease interventional devices, collaborate with healthcare providers to expand awareness and access to treatments, and address the challenges to meet the increasing demand for less invasive and effective solutions for valvular heart diseases.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2023-2029), aims to help readers to get a comprehensive understanding of global Valvular Disease Device market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
By Company
Edwards Lifesciences
Medtronic
Abbott
Boston Scientific
Venus Medtech
Meril Life Sciences
Braile Biomedica
Segment by Type
TAVR
TPVR
TMVR
Segment by Application
Hospitals
Ambulatory Surgical Centers
Cardiac Catheterization Laboratory
Consumption by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
The Valvular Disease Device report covers below items:
Chapter 1: Product Basic Information (Definition, Type and Application)
Chapter 2: Manufacturers’ Competition Patterns
Chapter 3: Country Level Sales Analysis
Chapter 4: Product Type Analysis
Chapter 5: Product Application Analysis
Chapter 6: Manufacturers’ Outline
Chapter 7: Industry Chain, Market Channel and Customer Analysis
Chapter 8: Market Opportunities and Challenges
Chapter 9: Market Conclusions
Chapter 10: Research Methodology and Data Source
Index1 Valvular Disease Device Market Overview
1.1 Product Overview and Scope of Valvular Disease Device
1.2 Valvular Disease Device Segment by Type
1.2.1 Global Valvular Disease Device Market Value Comparison by Type (2023-2029)
1.2.2 TAVR
1.2.3 TPVR
1.2.4 TMVR
1.3 Valvular Disease Device Segment by Application
1.3.1 Global Valvular Disease Device Market Value by Application: (2023-2029)
1.3.2 Hospitals
1.3.3 Ambulatory Surgical Centers
1.3.4 Cardiac Catheterization Laboratory
1.4 Global Valvular Disease Device Market Size Estimates and Forecasts
1.4.1 Global Valvular Disease Device Revenue 2018-2029
1.4.2 Global Valvular Disease Device Sales 2018-2029
1.4.3 Global Valvular Disease Device Market Average Price (2018-2029)
1.5 Assumptions and Limitations
2 Valvular Disease Device Market Competition by Manufacturers
2.1 Global Valvular Disease Device Sales Market Share by Manufacturers (2018-2023)
2.2 Global Valvular Disease Device Revenue Market Share by Manufacturers (2018-2023)
2.3 Global Valvular Disease Device Average Price by Manufacturers (2018-2023)
2.4 Global Valvular Disease Device Industry Ranking 2021 VS 2022 VS 2023
2.5 Global Key Manufacturers of Valvular Disease Device, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Valvular Disease Device, Product Type & Application
2.7 Valvular Disease Device Market Competitive Situation and Trends
2.7.1 Valvular Disease Device Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Valvular Disease Device Players Market Share by Revenue
2.7.3 Global Valvular Disease Device Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Valvular Disease Device Retrospective Market Scenario by Region
3.1 Global Valvular Disease Device Market Size by Region: 2018 Versus 2022 Versus 2029
3.2 Global Valvular Disease Device Global Valvular Disease Device Sales by Region: 2018-2029
3.2.1 Global Valvular Disease Device Sales by Region: 2018-2023
3.2.2 Global Valvular Disease Device Sales by Region: 2024-2029
3.3 Global Valvular Disease Device Global Valvular Disease Device Revenue by Region: 2018-2029
3.3.1 Global Valvular Disease Device Revenue by Region: 2018-2023
3.3.2 Global Valvular Disease Device Revenue by Region: 2024-2029
3.4 North America Valvular Disease Device Market Facts & Figures by Country
3.4.1 North America Valvular Disease Device Market Size by Country: 2018 VS 2022 VS 2029
3.4.2 North America Valvular Disease Device Sales by Country (2018-2029)
3.4.3 North America Valvular Disease Device Revenue by Country (2018-2029)
3.4.4 United States
3.4.5 Canada
3.5 Europe Valvular Disease Device Market Facts & Figures by Country
3.5.1 Europe Valvular Disease Device Market Size by Country: 2018 VS 2022 VS 2029
3.5.2 Europe Valvular Disease Device Sales by Country (2018-2029)
3.5.3 Europe Valvular Disease Device Revenue by Country (2018-2029)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Valvular Disease Device Market Facts & Figures by Country
3.6.1 Asia Pacific Valvular Disease Device Market Size by Country: 2018 VS 2022 VS 2029
3.6.2 Asia Pacific Valvular Disease Device Sales by Country (2018-2029)
3.6.3 Asia Pacific Valvular Disease Device Revenue by Country (2018-2029)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Southeast Asia
3.7 Latin America Valvular Disease Device Market Facts & Figures by Country
3.7.1 Latin America Valvular Disease Device Market Size by Country: 2018 VS 2022 VS 2029
3.7.2 Latin America Valvular Disease Device Sales by Country (2018-2029)
3.7.3 Latin America Valvular Disease Device Revenue by Country (2018-2029)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Valvular Disease Device Market Facts & Figures by Country
3.8.1 Middle East and Africa Valvular Disease Device Market Size by Country: 2018 VS 2022 VS 2029
3.8.2 Middle East and Africa Valvular Disease Device Sales by Country (2018-2029)
3.8.3 Middle East and Africa Valvular Disease Device Revenue by Country (2018-2029)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Valvular Disease Device Sales by Type (2018-2029)
4.1.1 Global Valvular Disease Device Sales by Type (2018-2023)
4.1.2 Global Valvular Disease Device Sales by Type (2024-2029)
4.1.3 Global Valvular Disease Device Sales Market Share by Type (2018-2029)
4.2 Global Valvular Disease Device Revenue by Type (2018-2029)
4.2.1 Global Valvular Disease Device Revenue by Type (2018-2023)
4.2.2 Global Valvular Disease Device Revenue by Type (2024-2029)
4.2.3 Global Valvular Disease Device Revenue Market Share by Type (2018-2029)
4.3 Global Valvular Disease Device Price by Type (2018-2029)
5 Segment by Application
5.1 Global Valvular Disease Device Sales by Application (2018-2029)
5.1.1 Global Valvular Disease Device Sales by Application (2018-2023)
5.1.2 Global Valvular Disease Device Sales by Application (2024-2029)
5.1.3 Global Valvular Disease Device Sales Market Share by Application (2018-2029)
5.2 Global Valvular Disease Device Revenue by Application (2018-2029)
5.2.1 Global Valvular Disease Device Revenue by Application (2018-2023)
5.2.2 Global Valvular Disease Device Revenue by Application (2024-2029)
5.2.3 Global Valvular Disease Device Revenue Market Share by Application (2018-2029)
5.3 Global Valvular Disease Device Price by Application (2018-2029)
6 Key Companies Profiled
6.1 Edwards Lifesciences
6.1.1 Edwards Lifesciences Corporation Information
6.1.2 Edwards Lifesciences Description and Business Overview
6.1.3 Edwards Lifesciences Valvular Disease Device Sales, Revenue and Gross Margin (2018-2023)
6.1.4 Edwards Lifesciences Valvular Disease Device Product Portfolio
6.1.5 Edwards Lifesciences Recent Developments/Updates
6.2 Medtronic
6.2.1 Medtronic Corporation Information
6.2.2 Medtronic Description and Business Overview
6.2.3 Medtronic Valvular Disease Device Sales, Revenue and Gross Margin (2018-2023)
6.2.4 Medtronic Valvular Disease Device Product Portfolio
6.2.5 Medtronic Recent Developments/Updates
6.3 Abbott
6.3.1 Abbott Corporation Information
6.3.2 Abbott Description and Business Overview
6.3.3 Abbott Valvular Disease Device Sales, Revenue and Gross Margin (2018-2023)
6.3.4 Abbott Valvular Disease Device Product Portfolio
6.3.5 Abbott Recent Developments/Updates
6.4 Boston Scientific
6.4.1 Boston Scientific Corporation Information
6.4.2 Boston Scientific Description and Business Overview
6.4.3 Boston Scientific Valvular Disease Device Sales, Revenue and Gross Margin (2018-2023)
6.4.4 Boston Scientific Valvular Disease Device Product Portfolio
6.4.5 Boston Scientific Recent Developments/Updates
6.5 Venus Medtech
6.5.1 Venus Medtech Corporation Information
6.5.2 Venus Medtech Description and Business Overview
6.5.3 Venus Medtech Valvular Disease Device Sales, Revenue and Gross Margin (2018-2023)
6.5.4 Venus Medtech Valvular Disease Device Product Portfolio
6.5.5 Venus Medtech Recent Developments/Updates
6.6 Meril Life Sciences
6.6.1 Meril Life Sciences Corporation Information
6.6.2 Meril Life Sciences Description and Business Overview
6.6.3 Meril Life Sciences Valvular Disease Device Sales, Revenue and Gross Margin (2018-2023)
6.6.4 Meril Life Sciences Valvular Disease Device Product Portfolio
6.6.5 Meril Life Sciences Recent Developments/Updates
6.7 Braile Biomedica
6.6.1 Braile Biomedica Corporation Information
6.6.2 Braile Biomedica Description and Business Overview
6.6.3 Braile Biomedica Valvular Disease Device Sales, Revenue and Gross Margin (2018-2023)
6.4.4 Braile Biomedica Valvular Disease Device Product Portfolio
6.7.5 Braile Biomedica Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Valvular Disease Device Industry Chain Analysis
7.2 Valvular Disease Device Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Valvular Disease Device Production Mode & Process
7.4 Valvular Disease Device Sales and Marketing
7.4.1 Valvular Disease Device Sales Channels
7.4.2 Valvular Disease Device Distributors
7.5 Valvular Disease Device Customers
8 Valvular Disease Device Market Dynamics
8.1 Valvular Disease Device Industry Trends
8.2 Valvular Disease Device Market Drivers
8.3 Valvular Disease Device Market Challenges
8.4 Valvular Disease Device Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
